# Codex Review: medical_monitoring_release_dossier_revalidation_20260803

Date: 2026-08-03
Direct Codex task; no delegated-agent output was used. The Hermes workflow
guard was used for task initialization and review-gate accounting only; no
Hermes execution dispatch was run.

## Verdict

**Pass for this bounded persisted-dossier diagnostic contract; the actual
commercial dossier remains absent/blocked.**

## Boundary Check

- Codex stayed inside the workbench and wrote only the declared module, tests,
  task context/review/metrics and active-slice evidence. The runner report path
  was not edited.
- The contract is offline/read-only; no service, provider, browser, SQLite,
  real project, frontend, medical-writing surface, 8911 or 5174 was touched.

## Codex Verification

- Reopened the canonical in-memory dossier contract and existing release-evidence
  revalidation contract before implementation.
- Focused persisted-dossier tests: **8 passed**; adjacent release/dossier/
  revalidation/migration/AI subset: **55 passed**.
- Full `tests/test_monitoring_*.py` regression: **1712 passed, 25 warnings in
  512.59s (0:08:32)**; existing warnings were retained.
- Compileall and Ruff passed; the active-slice empty diagnostic replay matched
  report SHA `c3688d1926620bf2f40b7d8df618d1dd1138bd250f167a547d46b5d8fb734171`.
- 8911/5174 have no listeners and protected frontend hashes are unchanged.
- Browser/runtime/UAT/real-project validation was intentionally not run because
  B6/C14 and upstream source/runtime gates remain blocked.

## Direct Work Review

- Traceability: persisted sections, control partitions, signoffs, residual risks,
  derived status/blockers and canonical dossier digest are reconstructed through
  the existing dossier dataclasses rather than reimplemented as a parallel rule set.
- File boundary: direct workspace-relative JSON path, regular-file, byte count and
  SHA-256 checks are fail-closed; unsafe, missing, symlink, malformed JSON and
  semantic drift produce typed issues.
- `fresh` is deliberately separate from `release_ready_observed`; a valid
  complete dossier does not grant authority.

## Residual Risk

- No persisted commercial dossier is currently declared; the active slice is
  intentionally `blocked` and does not create signoff, UAT, operational or
  release evidence.
- The contract still needs real controlled evidence and must be used after B6,
  source-token/CAS, approved-input, runtime, browser/scientific and UAT gates.
